abstract |
The present invention is related to the use of a compound of formula (I): n n n n n n n n n n wherein R 1 , R 2 , R 3 , R 4 and X are as defined herein, or an addition salt with an acid, for treating or preventing illnesses involving the nuclear receptors Nurr-1, also known as NR4A2, NOT, TINUR, RNR-1, and HZF3. |